Computer - Guided Inferior Alveolar Nerve Lateralization With Simultaneous Prosthetic Driven Implant Placement Will be Performed on 10 Surgical Sides (Mandibular Quadrants) to Evaluate the Postoperative Neurosensory Disturbances Following Guided Inferior Alveolar Nerve Lateralization
Launched by AYMAN M. ARAKEEP, MSC, PHD RESEARCHER · Apr 29, 2025
Trial Information
Current as of June 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Atrophic mandibular ridges distal to the mental foramen with residual alveolar bone height ≤ 8 mm above the IAN.
- • The width of the alveolar ridge ≥ 6 mm, 3mm down from the alveolar crest.
- Exclusion Criteria:
- • All patients suffering from any systemic disease that may contraindicate implant surgery or affect bone healing and osseointegration of implant.
- • Previous history of bone augmentation or implant placement in the site planned for nerve lateralization.
About Ayman M. Arakeep, Msc, Phd Researcher
Ayman M. Arakeep, MSc, PhD, is a dedicated clinical trial sponsor and researcher with extensive expertise in the field of biomedical sciences. With a strong academic background and a commitment to advancing healthcare, Dr. Arakeep leads innovative research initiatives that aim to enhance patient outcomes and contribute to the understanding of complex medical conditions. His collaborative approach and focus on rigorous scientific methodologies ensure the integrity and efficacy of clinical trials under his sponsorship, making significant contributions to the advancement of medical knowledge and therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, Al Gharbiyah, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported